Skip to search formSkip to main contentSkip to account menu

GYKI 12743

Known as: GYKI-12 743, GYKI-12743 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DioxanesPyridazines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Non-adrenergic regulation of microcirculation evoked by antidromic stimulation of the saphenous nerve in the rat skin.
Electrical stimulation of the peripheral stump of the cut and perineurally capsaicin-pretreated saphenous nerve evokes antidromic… 
1994
1994
Demonstration of the potassium channel opening activity of GYKI-12743 by 86Rb+ efflux studies.
It has been demonstrated that the novel antihypertensive compounds GYKI-12743 showed a potassium channel opening effect as… 
1992
1992
Studies in the field of pyridazine compounds. XXX: Synthesis of structural analogues of GYKI-12743 a long acting antihypertensive agent
1991
1991
GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
Using the pithed rat preparation it has been proven that GYKI-12743 exerted its alpha-adrenergic blocking action only at the… 
1990
1990
Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
1990
1990
GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
The electrophysiological effects of unilateral MCA occlusion for 45 minutes and subsequent recirculation for 3 hours were studied… 
1990
1990
Biochemical effects of GYKI-12 743.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)